Marker Therapeutics (MRKR) Change in Cash (2010 - 2026)

Marker Therapeutics (MRKR) has 17 years of Change in Cash data on file, last reported at -$1.4 million in Q1 2026.

• Change in Cash for Q1 2026 came in at -$1.4 million, up 74.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 million (down 17.91% YoY), and the FY2025 annual result was -$2.1 million, down 152.67% from the prior year.
• Change in Cash advanced to -$1.4 million in Q1 2026 per MRKR's latest filing, from -$1.9 million in the prior quarter.
• Over five years, Change in Cash peaked at $11.7 million in Q2 2023 and troughed at -$14.7 million in Q1 2022.
• A 5-year average of -$1.6 million and a median of -$2.4 million in 2023 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2022 and 2024: Change in Cash sank 134.01% in 2022, then surged 531.45% in 2024.
• A 5-year view of Change in Cash shows it stood at -$6.3 million in 2022, then surged by 62.47% to -$2.4 million in 2023, then surged by 531.45% to $10.2 million in 2024, then sank by 118.64% to -$1.9 million in 2025, then rose by 26.1% to -$1.4 million in 2026.
• Business Quant data shows MRKR's Change in Cash at -$1.4 million in Q1 2026, -$1.9 million in Q4 2025, and $7.1 million in Q3 2025.